Dark Forest Capital Management LP Janux Therapeutics, Inc. Transaction History
Dark Forest Capital Management LP
- $2.34 Billion
- Q2 2025
A detailed history of Dark Forest Capital Management LP transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Dark Forest Capital Management LP holds 46,856 shares of JANX stock, worth $1.21 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
46,856
Previous 44,672
4.89%
Holding current value
$1.21 Million
Previous $1.21 Million
10.28%
% of portfolio
0.05%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding JANX
# of Institutions
186Shares Held
56MCall Options Held
869KPut Options Held
652K-
Ra Capital Management, L.P. Boston, MA11.2MShares$288 Million5.65% of portfolio
-
Janus Henderson Group PLC London, X04.46MShares$115 Million0.05% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.92MShares$75.1 Million3.15% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$65 Million0.1% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$60.3 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.07B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...